299 related articles for article (PubMed ID: 30355737)
1. Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer.
Gerner EW; Bruckheimer E; Cohen A
J Biol Chem; 2018 Nov; 293(48):18770-18778. PubMed ID: 30355737
[TBL] [Abstract][Full Text] [Related]
2. Impact of dietary amino acids and polyamines on intestinal carcinogenesis and chemoprevention in mouse models.
Gerner EW
Biochem Soc Trans; 2007 Apr; 35(Pt 2):322-5. PubMed ID: 17371270
[TBL] [Abstract][Full Text] [Related]
3. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse.
Erdman SH; Ignatenko NA; Powell MB; Blohm-Mangone KA; Holubec H; Guillén-Rodriguez JM; Gerner EW
Carcinogenesis; 1999 Sep; 20(9):1709-13. PubMed ID: 10469614
[TBL] [Abstract][Full Text] [Related]
4. Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention.
Gerner EW; Meyskens FL; Goldschmid S; Lance P; Pelot D
Amino Acids; 2007 Aug; 33(2):189-95. PubMed ID: 17396214
[TBL] [Abstract][Full Text] [Related]
5. Polyamines as mediators of APC-dependent intestinal carcinogenesis and cancer chemoprevention.
Rial NS; Meyskens FL; Gerner EW
Essays Biochem; 2009 Nov; 46():111-24. PubMed ID: 20095973
[TBL] [Abstract][Full Text] [Related]
6. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
[TBL] [Abstract][Full Text] [Related]
7. Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis.
Ignatenko NA; Besselsen DG; Stringer DE; Blohm-Mangone KA; Cui H; Gerner EW
Nutr Cancer; 2008; 60 Suppl 1():30-5. PubMed ID: 19003578
[TBL] [Abstract][Full Text] [Related]
8. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
9. Targeting polyamines and inflammation for cancer prevention.
Babbar N; Gerner EW
Recent Results Cancer Res; 2011; 188():49-64. PubMed ID: 21253788
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs stimulate spermidine/spermine acetyltransferase and deplete polyamine content in colon cancer cells.
Turchanowa L; Dauletbaev N; Milovic V; Stein J
Eur J Clin Invest; 2001 Oct; 31(10):887-93. PubMed ID: 11737227
[TBL] [Abstract][Full Text] [Related]
11. Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation.
Gerner EW; Meyskens FL
Clin Cancer Res; 2009 Feb; 15(3):758-61. PubMed ID: 19188144
[TBL] [Abstract][Full Text] [Related]
12. Effects of cyclosporine and alpha-difluoromethylornithine on the growth of mouse colon cancer in vitro.
Saydjari R; Townsend CM; Barranco SC; Thompson JC
Life Sci; 1987 Jan; 40(4):359-66. PubMed ID: 3100897
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of polyamine analogs in cancer cells.
Huang Y; Pledgie A; Casero RA; Davidson NE
Anticancer Drugs; 2005 Mar; 16(3):229-41. PubMed ID: 15711175
[TBL] [Abstract][Full Text] [Related]
14. Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies.
Murray-Stewart T; Dunworth M; Lui Y; Giardiello FM; Woster PM; Casero RA
PLoS One; 2018; 13(8):e0202677. PubMed ID: 30138353
[TBL] [Abstract][Full Text] [Related]
15. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
16. A perspective of polyamine metabolism.
Wallace HM; Fraser AV; Hughes A
Biochem J; 2003 Nov; 376(Pt 1):1-14. PubMed ID: 13678416
[TBL] [Abstract][Full Text] [Related]
17. Polyamines as modifiers of genetic risk factors in human intestinal cancers.
Babbar N; Gerner EW
Biochem Soc Trans; 2003 Apr; 31(2):388-92. PubMed ID: 12653645
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.
Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene.
Gerner EW; Ignatenko NA; Lance P; Hurley LH
Ann N Y Acad Sci; 2005 Nov; 1059():97-105. PubMed ID: 16382048
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of various human tumors to inhibition of polyamine biosynthesis in vivo.
Saydjari R; Alexander RW; Upp JR; Barranco SC; Townsend CM; Thompson JC
Int J Cancer; 1991 Jan; 47(1):44-8. PubMed ID: 1985877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
